These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33803282)

  • 1. Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models.
    Park HJ; Jeong OY; Chun SH; Cheon YH; Kim M; Kim S; Lee SI
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model.
    Higuchi T; Takagi K; Tochimoto A; Ichimura Y; Hirose H; Sawada T; Shibata N; Harigai M; Kawaguchi Y
    Sci Rep; 2023 Nov; 13(1):19378. PubMed ID: 37938601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
    Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
    Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lee B; Roh JS; Jeong H; Kim Y; Lee J; Yun C; Park J; Kim DS; Lee J; So MW; Kim A; Sohn DH; Lee SG
    Anim Cells Syst (Seoul); 2024; 28(1):152-160. PubMed ID: 38645438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple subregions within the caveolin-1 scaffolding domain inhibit fibrosis, microvascular leakage, and monocyte migration.
    Reese CF; Chinnakkannu P; Tourkina E; Hoffman S; Kuppuswamy D
    PLoS One; 2022; 17(2):e0264413. PubMed ID: 35213624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and lung fibrosis induced by bleomycin in mice: a systematic review.
    Gülle S; Çelik A; Birlik M; Yılmaz O
    Reumatismo; 2024 Mar; 76(1):. PubMed ID: 38523580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Application of Nitrate Ameliorates Skin Fibrosis by Regulating ST2
    Gu J; Zhou Z; Xu S; Pan W; Wang J; Liu O; Wang S; Xu J
    J Invest Dermatol; 2024 Jun; ():. PubMed ID: 38945439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-Driven M2-Like Macrophages Are Critical for Skin Fibrosis in a Systemic Sclerosis Model.
    Gong P; Ding Y; Li W; Yang J; Su X; Tian R; Zhou Y; Wang T; Jiang J; Liu R; Fang J; Feng C; Shao C; Shi Y; Li P
    J Invest Dermatol; 2024 Apr; ():. PubMed ID: 38580106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
    Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y
    Arthritis Res Ther; 2023 Nov; 25(1):218. PubMed ID: 37957740
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin.
    Štorkánová H; Štorkánová L; Navrátilová A; Bečvář V; Hulejová H; Oreská S; Heřmánková B; Špiritović M; Bečvář R; Pavelka K; Vencovský J; Distler JHW; Šenolt L; Tomčík M
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Dysbiosis to Healthy Skin: Major Contributions of
    Rozas M; Hart de Ruijter A; Fabrega MJ; Zorgani A; Guell M; Paetzold B; Brillet F
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33803499
    [No Abstract]   [Full Text] [Related]  

  • 12. Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation.
    Liu W; Han X; Li Q; Sun L; Wang J
    Biomed Pharmacother; 2022 Sep; 153():113460. PubMed ID: 36076570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ability of Resveratrol to Attenuate Ovalbumin-Mediated Allergic Asthma Is Associated With Changes in Microbiota Involving the Gut-Lung Axis, Enhanced Barrier Function and Decreased Inflammation in the Lungs.
    Alharris E; Mohammed A; Alghetaa H; Zhou J; Nagarkatti M; Nagarkatti P
    Front Immunol; 2022; 13():805770. PubMed ID: 35265071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing.
    Liu X; Qin X; Qin H; Jia C; Yuan Y; Sun T; Chen B; Chen C; Zhang H
    Angiogenesis; 2021 Nov; 24(4):809-821. PubMed ID: 34028626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model.
    Tang J; Zhou X; Wu X; Lin S; Ming B; Zhong J; Wang B; Dong L
    Front Cell Infect Microbiol; 2021; 11():647201. PubMed ID: 34123867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibro-Stenosing Crohn's Disease: What Is New and What Is Next?
    Solitano V; Dal Buono A; Gabbiadini R; Wozny M; Repici A; Spinelli A; Vetrano S; Armuzzi A
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model.
    Principi L; Ferrini E; Ciccimarra R; Pagani L; Chinello C; Previtali P; Smith A; Villetti G; Zoboli M; Ravanetti F; Stellari FF; Magni F; Piga I
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Gut Microbial Diversity Augments Estrogen-Driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease.
    Chioma OS; Mallott E; Shah-Gandhi B; Wiggins Z; Langford M; Lancaster AW; Gelbard A; Wu H; Johnson JE; Lancaster L; Wilfong EM; Crofford LJ; Montgomery CG; Van Kaer L; Bordenstein S; Newcomb DC; Drake WP
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice.
    Qu Z; Dou W; Zhang K; Duan L; Zhou D; Yin S
    Arthritis Res Ther; 2022 Dec; 24(1):280. PubMed ID: 36564791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis.
    Drakopanagiotakis F; Stavropoulou E; Tsigalou C; Nena E; Steiropoulos P
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.